Alan Wilson Buys TROW Shares as Institutional Investors Adjust Positions

Alan Wilson acquired 462 shares of TROW, reflecting insider confidence in the company.

Key Points

  • Alan Wilson bought 462 shares of TROW on June 29, 2026, for about $52,843.56, signaling insider interest.
  • TROW shares traded near $113.69 on Wednesday, with recent institutional activity from BlackRock and Vanguard.
  • Analysts maintained their ratings on TROW, with price targets ranging from $89 to $111.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Alan Wilson purchased 462 shares of TROW on June 29, 2026, at an average price of $114.38 per share, totaling approximately $52,843.56. This insider transaction reflects an interest in the company from within.

Other Institutional Activity in TROW

BlackRock, Inc. increased its holdings of TROW by 2,005,718 shares, bringing its total to 22,769,675 shares valued at about $2.05 billion, marking a 9.7% increase. State Street Corp added 112,498 shares, now holding 14,272,295 shares worth roughly $1.29 billion, a 0.8% rise. Vanguard Capital Management LLC opened a new position with 14,161,471 shares valued at approximately $1.28 billion. Similarly, Vanguard Portfolio Management LLC initiated a stake with 10,169,583 shares worth around $916.7 million. In contrast, Goldman Sachs Group Inc. reduced its holdings by 320,353 shares to a total of 8,449,718 shares, worth about $761.7 million, a 3.7% decrease. Charles Schwab Investment Management Inc. also cut its position by 1,459,142 shares, holding 6,614,704 shares valued at $596.2 million, a decrease of 18.1%.

T. Rowe Price Group, Inc. Stock Up 2.2%

Shares of TROW traded near $113.69 on Wednesday. The company, known for its asset management services, has seen various institutional investors adjusting their positions. The stock's recent movements reflect broader trends in the financial sector.

Year to date

$TROW stock price

Daily closing prices, year to date. Not investment advice.

Insider Buying and Selling at T. Rowe Price Group, Inc.

Alongside Alan Wilson's purchase, other insiders were active. On June 30, 2026, Stevens Robert bought 537 shares, Wilson Alan added 691 shares, Donnelly William acquired 576 shares, and Maclellan Robert purchased 658 shares, all without a planned transaction. On June 29, 2026, Verma Richard bought 55 shares at $114.38, and Donnelly William acquired 142 shares at the same price.

Analysts Set New Price Targets

On June 26, 2026, Morgan Stanley maintained its hold rating for TROW with a price target of $109. Evercore ISI Group also maintained a hold rating with a target of $111 on June 8, 2026. Barclays held a sell rating with a target of $89 as of May 1, 2026. The consensus among analysts leans towards a hold rating, with an average price target reflecting cautious optimism.

Bottom Line

Alan Wilson's recent purchase of TROW shares is part of broader insider and institutional activity around the company. While insider buying can signal confidence, it's important to note that these transactions are reported after the fact. Investors often watch such moves for potential insights into company prospects.

Get T. Rowe Price Group, Inc. alerts

New 13F filings, insider trades, and analyst moves on $TROW, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.